InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the complete record of transactions filed by Welles Bernice R, Director. Director active across 2 companies, notably SPECTRUM PHARMACEUTICALS INC. Cumulatively, 2 disclosures have been published. Activity tracked since 17 June 2021. The latest transaction was filed on 17 June 2021 (Attribution). Regulator: SEC (Form 4). The full history is free.
2 of 2 declarations
Bernice R. Welles serves as a Board Member at SPECTRUM PHARMACEUTICALS INC. She plays a key role in the governance of the company, providing her expertise to guide strategic decisions.